NCT02356471
Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery No drug interventions supportive_care Not Available completed NCT02020707
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers treatment 1 completed NCT03508570
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis treatment 1 active_not_recruiting NCT05083338
Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy No drug interventions Not Available Not Available completed NCT03030287
A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer treatment 1 completed NCT03378128
Debulking Surgery in Ovarian Cancer No drug interventions treatment Not Available completed NCT00004909
Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer No drug interventions Not Available Not Available completed NCT00504257
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma treatment 2 completed NCT00189566
Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse treatment 2 completed NCT00436501
VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 1 / 2 completed NCT01494012
Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer treatment 1 terminated NCT00369954
Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin treatment 2 withdrawn NCT00653328
Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma treatment 2 terminated NCT00897806
Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer No drug interventions Not Available Not Available terminated NCT00030706
Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer treatment 2 completed NCT00005049
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer treatment 2 completed NCT01905163
Feasibility of Interval Debulking Surgery by Laparoscopy for Peritoneal Carcinosis in Chemosensitive Patients No drug interventions treatment 2 completed NCT00903630
Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 1 / 2 terminated NCT00357448
Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer treatment 1 completed NCT00101257
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer No drug interventions treatment 1 completed NCT00538031
Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT00748527
Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer treatment 2 terminated NCT00006391
Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT00625092
Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies treatment 1 completed NCT00825201
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity treatment 1 completed NCT00217568
Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer treatment 2 completed NCT00030446
Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT00004081
Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer treatment 2 completed NCT00004895
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery supportive_care 2 completed NCT02324595
Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study No drug interventions treatment 2 completed NCT00217555
Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 2 completed NCT00003450
Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer No drug interventions treatment 1 completed NCT00008138
S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer treatment 2 completed NCT00227721
Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer treatment 2 completed NCT00010179
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer treatment 2 completed NCT01074398
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182 No drug interventions Not Available Not Available unknown_status NCT01137071
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer treatment 2 terminated NCT00287885
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer treatment 1 completed NCT01166737
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer No drug interventions other Not Available completed NCT00287859
Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 1 terminated NCT00702299
Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer treatment 1 completed NCT01670799
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer other 0 completed NCT00652899
Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer treatment 2 terminated NCT00003896
S9912 Combination Chemo in Stage III Ovarian Cancer, treatment 2 completed NCT00331422
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer treatment 2 terminated NCT00112957
Vaccine Therapy in Patients With Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer treatment 2 completed NCT00003120
S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission treatment 3 completed NCT00043082
S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer treatment 3 completed NCT00466960
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy treatment 2 completed NCT00652691
Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer treatment 1 completed NCT00217529
Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer treatment 1 / 2 completed NCT00003944
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 completed NCT00436644
Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin treatment 2 completed NCT00354601
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer treatment 2 terminated NCT00803569
Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers treatment 1 completed NCT01096381
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor No drug interventions Not Available Not Available terminated NCT01281514
A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer treatment 1 completed NCT00993655
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer treatment 2 completed NCT00245050
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer supportive_care 3 completed NCT00536523
Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer No drug interventions Not Available Not Available terminated NCT00028743
Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 3 completed NCT00085384
PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer treatment 1 / 2 terminated NCT00550784
Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer treatment 1 completed NCT00870233
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life No drug interventions Not Available Not Available completed NCT04402333
Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival No drug interventions Not Available Not Available unknown_status NCT05792254
Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer No drug interventions treatment Not Available not_yet_recruiting NCT04295577
Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR No drug interventions Not Available Not Available unknown_status NCT04516447
A Study of ZN-c3 in Patients With Ovarian Cancer treatment 1 recruiting NCT04701645
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer No drug interventions diagnostic 1 recruiting NCT05597683
Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy No drug interventions treatment Not Available recruiting NCT02824328
A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers No drug interventions Not Available Not Available completed NCT06290193
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Primary Cytoreductive Surgery No drug interventions treatment 2 recruiting NCT00096993
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer treatment 2 completed NCT05445778
Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Ovarian, Fallopian Tube, or Peritoneal Cancer (GLORIOSA) treatment 3 recruiting NCT05080556
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer treatment 2 recruiting NCT04122885
Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis Not Available Not Available unknown_status NCT01083537
Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction treatment 1 / 2 terminated NCT00281632
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer treatment 2 completed NCT01821859
Abraxane/Bevacizumab treatment 2 terminated NCT01104675
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer treatment 2 completed NCT01767675
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 active_not_recruiting NCT04846842
A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer treatment 2 unknown_status NCT02470299
Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients basic_science Not Available active_not_recruiting NCT01610206
A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer treatment 2 completed NCT02487849
HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma treatment 2 withdrawn NCT03023319
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors treatment 1 completed NCT05581719
A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy treatment 1 / 2 terminated NCT01556841
The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer treatment 2 completed NCT00683241
A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer No drug interventions treatment 1 completed NCT01580696
Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer treatment 1 / 2 completed NCT02349958
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy No drug interventions treatment 2 unknown_status NCT01223235
Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab treatment Not Available completed NCT00461786
A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer treatment 2 completed NCT02728622
Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane treatment 3 completed NCT00669422
ChemoFx® PRO - A Post-Market Data Collection Study No drug interventions Not Available Not Available terminated NCT02534922
Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer treatment 1 unknown_status NCT02728830
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers treatment 0 completed NCT05960630
MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer No drug interventions treatment Not Available recruiting NCT03693248
Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer treatment 3 unknown_status NCT04196257
BP1001-A in Patients With Advanced or Recurrent Solid Tumors treatment 1 recruiting NCT05041257
Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO) treatment 2 active_not_recruiting NCT04611126
T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer treatment 1 / 2 terminated NCT02433626
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies treatment 1 unknown_status NCT05009082
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer treatment 3 recruiting NCT05001282
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) No drug interventions treatment 1 / 2 terminated NCT01248273
Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission treatment 1 completed NCT01188876
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer treatment 1 / 2 completed NCT03332576
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer treatment 1 completed NCT00634894
Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 2 withdrawn NCT01248962
Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer treatment 2 completed NCT00856180
Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies treatment 2 completed NCT00753480
A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer No drug interventions treatment 1 suspended NCT02657889
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer treatment 1 / 2 completed NCT06087289
A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 / 2 recruiting NCT00501644
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer treatment 2 completed NCT02855944
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients treatment 3 completed NCT00850772
Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer No drug interventions supportive_care 3 completed NCT05912972
Development and Management of Registry in Patients With Gynecologic Cancer in Korea No drug interventions Not Available Not Available recruiting NCT04027868
Genomic BRCA and Extensive ovArian Cancer Testing No drug interventions Not Available Not Available completed NCT05080946
Using Aspirin to Improve Immunological Features of Ovarian Tumors treatment 0 recruiting NCT00672295
PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer treatment 1 completed NCT04209855
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression treatment 3 active_not_recruiting NCT00491855
Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis treatment 1 completed NCT02915523
Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer treatment 1 / 2 completed NCT03657043
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) treatment 2 completed NCT04296890
A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression treatment 3 completed NCT06445621
Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test No drug interventions Not Available Not Available recruiting NCT01704651
Accelerating Gastrointestinal Recovery prevention 3 completed NCT02758951
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases treatment 2 / 3 active_not_recruiting NCT06144853
The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study. No drug interventions Not Available Not Available recruiting NCT01669798
BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer treatment 2 completed NCT01493505
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer treatment 3 terminated NCT01471483
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer No drug interventions Not Available Not Available active_not_recruiting NCT00505661
Letrozole in Patients With Ovarian Tumors treatment 2 terminated NCT01091428
Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer treatment 2 completed NCT02865811
Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer treatment 2 completed NCT03359811
Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway treatment 3 completed NCT05335993
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. treatment 2 active_not_recruiting NCT05887609
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib treatment 2 recruiting NCT01482715
A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) treatment 1 / 2 completed NCT05071937
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer treatment 2 recruiting NCT00055432
Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer treatment 2 terminated NCT03430700
Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer treatment 2 active_not_recruiting NCT00910000
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer treatment 1 / 2 terminated NCT00692900
Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer treatment 1 completed NCT00408070
Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 2 terminated NCT00230542
Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer treatment 2 completed NCT01447706
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers treatment 2 completed NCT03211806
Detecting Activity to Support Healing No drug interventions supportive_care Not Available completed NCT01649336
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer treatment 1 completed NCT01968213
Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) treatment 3 completed NCT02668913
LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer No drug interventions diagnostic Not Available completed NCT04022213
A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum treatment 2 recruiting NCT00268918
Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients treatment 1 completed NCT00652119
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin treatment 1 unknown_status NCT04498117
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery treatment 3 active_not_recruiting NCT04676334
CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib treatment 3 completed NCT05179824
Tempus Priority Study: A Pan-tumor Observational Study No drug interventions Not Available Not Available recruiting NCT05708924
MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer treatment 1 suspended NCT04785716
Real-life Use of Niraparib in a Patient Access Program in Norway Not Available Not Available completed NCT00267696
Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer treatment 2 completed NCT00189358
A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based Therapy treatment 2 completed NCT02489058
A Study of Long-Term Responders on Olaparib No drug interventions Not Available Not Available completed NCT06451263
Nudge to Gynecologic Oncology No drug interventions supportive_care Not Available active_not_recruiting NCT04088786
Phase I Trial HIPEC With Nal-irinotecan treatment 1 completed NCT01370122
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies No drug interventions Not Available Not Available completed NCT05718726
Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI) No drug interventions Not Available Not Available recruiting NCT05406674
Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer treatment 2 recruiting NCT01276574
Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT No drug interventions Not Available Not Available active_not_recruiting NCT00801320
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer No drug interventions other Not Available completed NCT05353582
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases No drug interventions treatment 2 not_yet_recruiting NCT05591131
Genetic Testing in African Americans No drug interventions health_services_research Not Available recruiting NCT03976973
BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei treatment 2 unknown_status NCT01065662
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies treatment 1 completed NCT02873962
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib treatment 2 active_not_recruiting NCT00343044
Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers treatment 2 completed NCT00768144
Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma treatment 2 completed NCT01891344
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) treatment 2 completed NCT01099644
Intraperitoneal RIT With 131I-8H9 for Pts With DSRCT and Other Solid Tumors Involving the Peritoneum No drug interventions treatment 1 terminated NCT01262040
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive No drug interventions diagnostic Not Available completed NCT02741167
Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy No drug interventions Not Available Not Available unknown_status NCT06184867
Choices About Genetic Testing And Learning Your Risk With Smart Technology No drug interventions health_services_research 0 recruiting NCT00515372
Depression Treatment and Screening in Ovarian Cancer Patients No drug interventions treatment 1 active_not_recruiting NCT01591772
Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer No drug interventions Not Available Not Available completed NCT01661868
Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer treatment 2 withdrawn NCT03126812
Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer treatment 1 / 2 completed NCT00499512
Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer No drug interventions Not Available Not Available unknown_status NCT01048814
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases No drug interventions Not Available Not Available completed NCT04983550
Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC treatment 2 unknown_status NCT02973750
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer No drug interventions Not Available Not Available completed NCT00061308
Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer treatment 2 completed NCT01416038
Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer treatment 1 completed NCT04907643
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes No drug interventions supportive_care Not Available recruiting NCT00637390
A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. treatment 1 terminated NCT05622890
A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer treatment 3 recruiting NCT04537702
Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer Patients No drug interventions supportive_care Not Available completed NCT03280511
Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients prevention 2 recruiting NCT02834975
Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC). treatment 2 terminated NCT03210298
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) No drug interventions Not Available Not Available unknown_status NCT05256576
KORE-Innovation: a Prospective, Multi-site Clinical Trial to Implement and Analyse the Effects of an Innovative Perioperative Care Pathway to Reduce Complications for Patients With Ovarian Cancer No drug interventions health_services_research Not Available recruiting